ORION BIOTECH OPPORTUNTES CO (ORIAW)
Institutional ownership reported to the SEC as of Q1 2023, across 7 quarters.
23
Reporting holders
$1.4M
Reported value
86.8%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 23 | $1.4M | 2,333,676 | 0 | 0 | 4 | 86.8% |
| Q4 2022 | 22 | $865.3K | 2,009,241 | 3 | 2 | 1 | 63.9% |
| Q3 2022 | 28 | $911.4K | 2,314,644 | 2 | 1 | 1 | 60.2% |
| Q2 2022 | 27 | $886.8K | 2,201,252 | 1 | 1 | 3 | 61.3% |
| Q1 2022 | 27 | $1.4M | 2,199,956 | 6 | 1 | 5 | 40.3% |
| Q4 2021 | 22 | $2.3M | 1,836,625 | 4 | 1 | 0 | 23.2% |
| Q3 2021 | 17 | $1.7M | 1,298,093 | 17 | 0 | 0 | 32.8% |